Drugs / Y-2 Sublingual Tablet
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05940883 | Sep → Nov 2023 | — | Simcere Pharmaceutical Co., Ltd | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Y-2 Sublingual Tablet | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05940883 ↗ |
| Route | Other | “sublingually” NCT05940883 ↗ |